Literature DB >> 1982659

Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites.

H Canton1, L Verrièle, F C Colpaert.   

Abstract

We determined the affinity of several typical and atypical antipsychotics for the 5-HT1C and 5-HT2 sites using radioligand binding assays. Most of the antipsychotics tested appeared to bind to 5-HT2 sites with affinities that were fairly high (i.e. pKi values between 7 and 9) and significantly higher than for 5-HT1C sites. In contrast, clozapine was found to have a significantly higher affinity for 5-HT1C than for 5-HT2 sites. Clozapine had the highest affinity for 5-HT1C sites of all the compounds tested. These findings are consistent with the hypothesis that an interaction with 5-HT2 receptors may be relevant to the clinical activity of typical antipsychotics. The findings also suggest, however, that an interaction with 5-HT1C sites may be relevant to the mechanism of clinical action of clozapine and, perhaps, of other atypical antipsychotics.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1982659     DOI: 10.1016/0014-2999(90)94100-c

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  23 in total

1.  ERK and β-arrestin interaction: a converging point of signaling pathways for multiple types of cell surface receptors.

Authors:  Haifeng Eishingdrelo; Wei Sun; Hua Li; Li Wang; Alex Eishingdrelo; Sheng Dai; John C McKew; Wei Zheng
Journal:  J Biomol Screen       Date:  2014-10-31

Review 2.  Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.

Authors:  Christine Konradi; Stephan Heckers
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

3.  Pharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT2 receptor antagonist.

Authors:  A Doble; D Girdlestone; O Piot; D Allam; J Betschart; A Boireau; A Dupuy; C Guérémy; J Ménager; J L Zundel
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

Review 4.  Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology.

Authors:  P De Deurwaerdère; M Lagière; M Bosc; S Navailles
Journal:  Exp Brain Res       Date:  2013-04-25       Impact factor: 1.972

5.  Clozapine: an appraisal of its pharmacoeconomic benefits in the treatment of schizophrenia.

Authors:  A Fitton; P Benfield
Journal:  Pharmacoeconomics       Date:  1993-08       Impact factor: 4.981

6.  Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor.

Authors:  E P Pälvimäki; B L Roth; H Majasuo; A Laakso; M Kuoppamäki; E Syvälahti; J Hietala
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

7.  Effects of serotonergic agents on apomorphine-induced locomotor activity.

Authors:  K A Young; R Zavodny; P B Hicks
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat.

Authors:  C Johansson; D M Jackson; L Svensson
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

9.  A comparison of the neuro-endocrinological and temperature effects of DU 29894, flesinoxan, sulpiride and haloperidol in normal volunteers.

Authors:  P de Koning; M H de Vries
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

10.  Effects of dopamine and fluphenazine on field potential amplitude in the salamander olfactory bulb.

Authors:  M R Gurski; K A Hamilton
Journal:  Exp Brain Res       Date:  1996-03       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.